172 related articles for article (PubMed ID: 23873254)
1. Paired responses to intravitreal bevacizumab in diabetic macular edema: predictors of response in the fellow eye.
Karth PA; Chang A; Wirostko W
Graefes Arch Clin Exp Ophthalmol; 2014 Feb; 252(2):207-11. PubMed ID: 23873254
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of intravitreal anti-vascular endothelial growth factor or steroid injection in diabetic macular edema according to fluid turbidity in optical coherence tomography.
Lee K; Chung H; Park Y; Sohn J
Korean J Ophthalmol; 2014 Aug; 28(4):298-305. PubMed ID: 25120338
[TBL] [Abstract][Full Text] [Related]
3. Fellow eye effect of unilateral intravitreal bevacizumab injection in eyes with diabetic macular edema.
Hanhart J; Tiosano L; Averbukh E; Banin E; Hemo I; Chowers I;
Eye (Lond); 2014 Jun; 28(6):646-53. PubMed ID: 24858528
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema.
Faghihi H; Roohipoor R; Mohammadi SF; Hojat-Jalali K; Mirshahi A; Lashay A; Piri N; Faghihi Sh
Eur J Ophthalmol; 2008; 18(6):941-8. PubMed ID: 18988166
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial.
Lim JW; Lee HK; Shin MC
Ophthalmologica; 2012; 227(2):100-6. PubMed ID: 21997197
[TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomographic patterns in diabetic macula edema can predict the effects of intravitreal bevacizumab injection as primary treatment.
Wu PC; Lai CH; Chen CL; Kuo CN
J Ocul Pharmacol Ther; 2012 Feb; 28(1):59-64. PubMed ID: 21992557
[TBL] [Abstract][Full Text] [Related]
7. Correlation of fundus autofluorescence with spectral-domain optical coherence tomography and vision in diabetic macular edema.
Chung H; Park B; Shin HJ; Kim HC
Ophthalmology; 2012 May; 119(5):1056-65. PubMed ID: 22342014
[TBL] [Abstract][Full Text] [Related]
8. Visual outcome after intravitreal bevacizumab depends on the optical coherence tomographic patterns of patients with diffuse diabetic macular edema.
Shimura M; Yasuda K; Yasuda M; Nakazawa T
Retina; 2013 Apr; 33(4):740-7. PubMed ID: 23222391
[TBL] [Abstract][Full Text] [Related]
9. Repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema.
Solaiman KA; Diab MM; Dabour SA
Retina; 2013 Sep; 33(8):1623-9. PubMed ID: 23538584
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA
Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
[TBL] [Abstract][Full Text] [Related]
11. Combined Intravitreal Triamcenolone Acetonide and Bevacizumab for Refractory Diabetic Macular Edema.
Arain MA; Muzaffar W; Farooq O; Azhar MN
J Coll Physicians Surg Pak; 2018 Aug; 28(8):603-606. PubMed ID: 30060788
[TBL] [Abstract][Full Text] [Related]
12. Vision-related quality of life and visual function following intravitreal bevacizumab injection for persistent diabetic macular edema after vitrectomy.
Okamoto Y; Okamoto F; Hiraoka T; Oshika T
Jpn J Ophthalmol; 2014 Jul; 58(4):369-74. PubMed ID: 24777841
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
[TBL] [Abstract][Full Text] [Related]
15. Predicting 1-month response of macular edema to intravitreal bevacizumab from 1-hour response.
Ma DJ; Park KH; Woo SJ
Can J Ophthalmol; 2014 Jun; 49(3):267-72. PubMed ID: 24862773
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up.
Arevalo JF; Sanchez JG; Fromow-Guerra J; Wu L; Berrocal MH; Farah ME; Cardillo J; RodrÃguez FJ;
Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):735-43. PubMed ID: 19189118
[TBL] [Abstract][Full Text] [Related]
17. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.
Sonoda Y; Arimura N; Shimura M; Sakamoto T
Retina; 2011 Feb; 31(2):290-7. PubMed ID: 21102366
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Response between Both Eyes to First- and Second-Line Anti-VEGF Therapy in Diabetic Macular Edema.
Tiosano L; Ayalon A; Banin E; Averbukh E; Jaouni T; Chowers I
Curr Eye Res; 2021 Apr; 46(4):539-545. PubMed ID: 32804540
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
